Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
24 Cards in this Set
- Front
- Back
Aspirin mechanism
|
Irreversible inhibits cycoloxygenase by covalent binding which decreases thromboxane and prostaglandin synthesis
|
|
Aspirin mechanism
|
Irreversible inhibits cycoloxygenase by covalent binding which decreases thromboxane and prostaglandin synthesis
|
|
Clinical use of aspirin
Low dose Intermediate dose High dose |
Low dose (<300mg) used for decr platelet aggregation
Intermediate dose (300-2400mg): antipyretic and analgesic High dose (2400-4000mg): antiinflammatory |
|
Toxicity of aspirin
|
GI upset
Chronic use can lead to ARF, interstitial nephritis, upper GI bleeding Reye's syndrome in children w/viral infx |
|
NSAIDs mechanism
|
Ibuprofen, naproxen, indomethacin, ketorolac
Reversible inhibit cyrlocoxygenase (both COX1 and 2) Block prostaglandin synthesis |
|
Clincal use of Nsaids
|
Antipyretic
Analgesic Antiinflammatory |
|
Toxicity of NSAIDs
|
Renal damage
Aplastic anemia GI distress Ulcers |
|
Celecoxib mechanism
|
Reversibly inhibits COX2 found in inflammatory cells and vascular endothelium (mediates inflammation and pain); spares COX1 (which helps maintain gastric mucosa)
|
|
Clinical use of celecoxib
|
Rheumatoid and osteoarthritis
|
|
Toxicity of celecoxib
|
Incr risk of thrombosis
Sulfa allergy |
|
Acetaminophen mechanism
|
Reversibly inhibits cyclooxygenase mostly in the CNS; inactivate dperipherally
|
|
Acetaminophen clinical use
|
Antipyretic, analgesic
No antiinflammatory properties |
|
Acetaminophen toxicity
|
Overdose produces hepatic necrosis (metabolite depletes glutathione and forms toxic tissue adducts in liver)
|
|
NSAID+antiplatelet activity
|
Aspirin
|
|
NSAID minus antiinflammatory activity
|
Acetimenophen
|
|
Bisphosphanates
(a) name (b) mechanism (c) clinical use (d) toxicity |
(a) etidronate, pamidronate, alendronate, risendronate
(b) inhibit osteoclastic activityl reduce both formation and resorption of hydroxyappetite (c) corrosive esophagitis, nausea, diarrhea |
|
Colchicine
(a) clinical use (b) mechanism (c) toxicity |
(a) acute gout
(b) binds and stabilizes tubulin to inhibit polymerization of microtubules; impairs leukocyte chemotaxis and degranulation (c) Gi side effects esp orally |
|
What other medication is used for acute gouty arthritis attacks?
|
Indomethacin
|
|
Probenecid
(a) clinical use (b) mechanism |
(a) chronic gout
(b) inhibits reabsorption of uric acid in PCT |
|
Allopurinol
(a) clinical use (b) mechanism |
(a) chronic gout; also used in lymphoma and leukemia to prevent tumor lysis associated urate nephropathy
(b) inhibit xanthine oxidase to decrease conversion of xanthine to uric acid |
|
What is the effect of allopurinol on azathioprine and 6-MP?
|
Increase concentrations b/c both are normally metabolized by xanthine oxidase
|
|
What medications should you not give to a gout patient?
|
Salicylates
All but the highest doses depress uric acid clearance. |
|
Etanercept
(a) mechanism (c) clinical use |
(a) recombinant form of TNF receptor that binds free TNF
(b) Rheumatoid arthritis, psoriasis, ankylosing spondylitis |
|
Infliximab
(a) mechanism (b) clinical use |
(a) Anti TNF antibody
(b) chron's disease, RA, anklyosing spondylitis |